SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-21-058634
Filing Date
2021-11-12
Accepted
2021-11-12 15:45:14
Documents
6
Period of Report
2021-11-12

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea150506-6k_mainzbiomed.htm 6-K 20008
2 UNDERWRITING AGREEMENT, DATED NOVEMBER 4, 2021, BETWEEN MAINZ BIOMED N.V. AND BO ea150506ex1-1_mainzbiomed.htm EX-1.1 313061
3 DEED OF CONVERSION, DATED NOVEMBER 9, 2021 ea150506ex3-1_mainzbiomed.htm EX-3.1 217422
4 PRESS RELEASE, DATED NOVEMBER 5, 2021 ea150506ex99-1_mainzbiomed.htm EX-99.1 8493
5 PRESS RELEASE, DATED NOVEMBER 8, 2021 ea150506ex99-2_mainzbiomed.htm EX-99.2 8309
6 GRAPHIC ex3-1_001.jpg GRAPHIC 2713
  Complete submission text file 0001213900-21-058634.txt   572235
Mailing Address ROBERT KOCH STRASSE 50 MAINZ 2M 55129
Business Address ROBERT KOCH STRASSE 50 MAINZ 2M 55129 49 6131 5542860
MAINZ BIOMED N.V. (Filer) CIK: 0001874252 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41010 | Film No.: 211403047
SIC: 2834 Pharmaceutical Preparations